Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples

Keyphrases

• Non-small Cell Lung Cancer (NSCLC) 100%
• Programmed Death-ligand 1 (PD-L1) 100%
• Ventana 100%
• SP263 100%
• Endobronchial Ultrasound-guided Fine Needle Aspiration 100%
• Histology 80%
• Programmed Death-ligand 1 Expression 60%
• Staining Intensity 40%
• Intensity Score 40%
• Tumor Proportion Score 40%
• Cytology Cell Block 40%
• Tumor Cells 20%
• Immunohistochemistry 20%
• Intraclass Correlation Coefficient 20%
• Treatment Landscape 20%
• Cytological Samples 20%
• Concordance Rate 20%
• Negative Cytology 20%
• Primary Staging 20%
• Immunohistochemical Tests 20%
• Primary Diagnostics 20%
• Programmed death-1 Inhibitor 20%
• 95% Confidence Interval 20%

Medicine and Dentistry

• Aortic Aneurysm Endovascular Graft 100%
• Non Small Cell Lung Cancer 100%
• Fine-Needle Aspiration 100%
• Programmed Death 1 Ligand 1 100%
• Endobronchial Ultrasonography 100%
• Cytotechnology 87%
• Histology 50%
• Neoplasm 25%
• Immunohistochemistry 25%
• Tumor Cell 12%